The FDA derives just under half of its yearly funding from pharma user fees, which help support its operations and fund employee salaries. An analysis from AgencyIQ suggests that the agency is dangerously close to losing it all.
Source: FDA Faces ‘Catastrophic Collapse’ as Massive Layoffs Endanger User Fee Program – BioSpace